Provided by Tiger Fintech (Singapore) Pte. Ltd.

Editas Medicine

3.15
-0.1100-3.37%
Post-market: 3.190.0400+1.27%19:44 EDT
Volume:1.28M
Turnover:4.04M
Market Cap:263.70M
PE:-1.04
High:3.28
Open:3.28
Low:3.10
Close:3.26
Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
12 May

Editas Medicine Inc expected to post a loss of 59 cents a share - Earnings Preview

Reuters
·
09 May

H.C. Wainwright Remains a Buy on Editas Medicine (EDIT)

TIPRANKS
·
06 May

Press Release: ONE Gas Announces First Quarter 2025 Financial Results; Expects to Achieve the Upper Half of 2025 Financial Guidance; Declares Second Quarter Dividend

Dow Jones
·
06 May

Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May

GlobeNewswire
·
06 May

Editas Medicine Inc expected to post a loss of 58 cents a share - Earnings Preview

Reuters
·
02 May

Editas Medicine (EDIT) Gets a Sell from Bank of America Securities

TIPRANKS
·
30 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
30 Apr

Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting

GlobeNewswire
·
29 Apr

Editas Medicine Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
28 Apr

HC Wainwright Initiates Coverage on Editas Medicine With Buy Rating, $3 Price Target

MT Newswires Live
·
28 Apr

Why Is Editas (EDIT) Down 37.1% Since Last Earnings Report?

Zacks
·
04 Apr

Dyne Therapeutics Names Erick Lucera as CFO

MT Newswires Live
·
21 Mar

Dyne Therapeutics Names Editas Medicine's Lucera as CFO

Dow Jones
·
21 Mar

BRIEF-Editas Medicine Announces Chief Financial Officer Transition

Reuters
·
21 Mar

Editas Medicine CFO Erick Lucera to step down, Amy Parison to succeed

TIPRANKS
·
21 Mar

Press Release: Editas Medicine Announces Chief Financial Officer Transition

Dow Jones
·
21 Mar

Cautious Hold Rating on Editas Medicine Amid Early Development Stage and Long-Term Milestones

TIPRANKS
·
15 Mar

Here's Why Editas Medicine (NASDAQ:EDIT) Must Use Its Cash Wisely

Simply Wall St.
·
13 Mar

Is Lithia Motors Inc. (NYSE:LAD) Among the Most Promising Car Stocks According to Hedge Funds?

Insider Monkey
·
12 Mar